X4 Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results.benzinga_article·Aug 7 at 11:04 AMXFOR-1.51%
X4 Pharmaceuticals (NASDAQ:XFOR) Releases Earnings Results, Beats Expectations By $0.05 EPSMarket Beat·Aug 6 at 06:56 PMXFOR-1.51%
X4 Pharmaceuticals Q2 FY26 net loss narrows to $16.2 million; revenue rises to $8.81 millionPUBT·Aug 6 at 04:47 PMXFOR-1.51%
X4 Pharmaceuticals Q2 2026 Earnings: License Revenue Helps Narrow the Net LossTradingKey·Aug 6 at 04:12 PMXFOR-1.51%
X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 eachPUBT·Aug 3 at 03:39 PMXFOR-1.51%
X4 Pharmaceuticals (XFOR) to Release Quarterly Earnings on ThursdayMarket Beat·Jul 30 at 03:56 AMXFOR-1.51%
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Receives Average Rating of "Moderate Buy" from AnalystsMarket Beat·Jul 25 at 03:29 AMXFOR-1.51%
Wall Street analyst calls: DA Davidson starts AGCO at buy; Citi cuts Pepsi to neutral; Wells Fargo upgrades SeagateCoinLive·Jul 10 at 07:33 AMMLCO+0.37%AGCO-0.15%
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Unusual Whales·Jul 7 at 03:32 PMXFOR-1.51%
X4 Pharmaceuticals issues inducement stock options for 750,000 shares at $4.03 eachPUBT·Jul 7 at 03:30 PMXFOR-1.51%
X4 Pharmaceuticals appoints CAMP4 CFO Kelly Gold to board, audit committeePUBT·Jul 1 at 06:01 AMXFOR-1.51%CAMP+0.90%
